{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:38:56Z","timestamp":1787798336379,"version":"build-2784847793"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.phrs.2021.105977","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T03:42:38Z","timestamp":1637120558000},"page":"105977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance"],"prefix":"10.1016","volume":"175","author":[{"given":"Yan-Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Da","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Qiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.phrs.2021.105977_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"issue":"10055","key":"10.1016\/j.phrs.2021.105977_bib2","first-page":"2023","volume":"388","author":"Smolen","year":"2018","journal-title":"Rheum. Arthritis"},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00325481.2018.1412799","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited","volume":"130","author":"Walker","year":"2018","journal-title":"Postgrad. Med."},{"issue":"7553","key":"10.1016\/j.phrs.2021.105977_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"issue":"9894","key":"10.1016\/j.phrs.2021.105977_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Coxib and traditional NSAID Trialists\u2019 (CNT)","year":"2013","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.phrs.2021.105977_bib6","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.2174\/092986709789578178","article-title":"Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs) -- a critical review","volume":"16","author":"Koeberle","year":"2009","journal-title":"Curr. Med Chem."},{"issue":"22","key":"10.1016\/j.phrs.2021.105977_bib7","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N. Engl. J. Med"},{"issue":"20","key":"10.1016\/j.phrs.2021.105977_bib8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.116.023164","article-title":"Aspirin for primary cardiovascular risk prevention and beyond in diabetes mellitus","volume":"134","author":"Capodanno","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib9","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/cr068365a","article-title":"Recent developments in the synthesis of prostaglandins and analogues","volume":"107","author":"Das","year":"2007","journal-title":"Chem. Rev."},{"issue":"42","key":"10.1016\/j.phrs.2021.105977_bib10","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M003504200","article-title":"Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis","volume":"275","author":"Tanioka","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/abbi.2001.2614","article-title":"Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages","volume":"397","author":"Lazarus","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"39","key":"10.1016\/j.phrs.2021.105977_bib12","doi-asserted-by":"crossref","first-page":"37937","DOI":"10.1074\/jbc.M305108200","article-title":"Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2","volume":"278","author":"Murakami","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"39","key":"10.1016\/j.phrs.2021.105977_bib13","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1523\/JNEUROSCI.2190-05.2005","article-title":"Downregulation of cytosolic prostaglandin E2 synthase results in decreased nociceptive behavior in rats","volume":"25","author":"Hofacker","year":"2005","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2007.07.180","article-title":"Knockout mice lacking cPGES\/p23, a constitutively expressed PGE2 synthetic enzyme, are peri-natally lethal","volume":"362","author":"Nakatani","year":"2007","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.phrs.2021.105977_bib15","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1074\/jbc.M112.418475","article-title":"Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro","volume":"288","author":"Takusagawa","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2021.105977_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2008.10.003","article-title":"Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis","volume":"88","author":"Jania","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib17","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1038\/s41598-017-10271-8","article-title":"Aggravation of acute kidney injury by mPGES-2 down regulation is associated with autophagy inhibition and enhanced apoptosis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.gene.2013.05.069","article-title":"A current review of molecular mechanisms regarding osteoarthritis and pain","volume":"527","author":"Lee","year":"2013","journal-title":"Gene"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2021.105977_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.plefa.2013.04.004","article-title":"The role of prostaglandin E2 in human vascular inflammation","volume":"89","author":"Gomez","year":"2013","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/147894","article-title":"Role of COX-2\/mPGES-1\/Prostaglandin E2 Cascade in Kidney Injury","volume":"2015","author":"Jia","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2021.105977_bib21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2741\/1341","article-title":"Cytokines and fever","volume":"9","author":"Conti","year":"2004","journal-title":"Front Biosci."},{"issue":"13","key":"10.1016\/j.phrs.2021.105977_bib22","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1111\/bph.12677","article-title":"Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation","volume":"171","author":"Bauer","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coph.2006.09.004","article-title":"Prostaglandins and adenosine in the regulation of sleep and wakefulness","volume":"7","author":"Huang","year":"2007","journal-title":"Curr. Opin. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2018-00075","article-title":"Ovulation: parallels with inflammatory processes","volume":"40","author":"Duffy","year":"2019","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2021.105977_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/med.21306","article-title":"Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates","volume":"34","author":"Bahia","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharm. Rev."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2183\/pjab.93.044","article-title":"Prostaglandin terminal synthases as novel therapeutic targets","volume":"93","author":"Hara","year":"2017","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.phrs.2021.105977_bib28","doi-asserted-by":"crossref","first-page":"646\/1","DOI":"10.3389\/fphar.2017.00646","article-title":"Microsomal prostaglandin E synthase-1 expression in inflammatory conditions is downregulated by dexamethasone: seminal role of the regulatory phosphatase MKP-1","volume":"8","author":"Tuure","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.108.138776","article-title":"MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation","volume":"326","author":"Xu","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1476-5381.2010.01020.x","article-title":"Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense","volume":"162","author":"Siemoneit","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105977_bib31","article-title":"A review on mPGES-1 inhibitors: from preclinical studies to clinical applications","volume":"147","author":"Bergqvist","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"15","key":"10.1016\/j.phrs.2021.105977_bib32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4155\/fmc.11.136","article-title":"Identification and development of mPGES-1 inhibitors: where we are at?","volume":"3","author":"Chang","year":"2011","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.06.022","article-title":"Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders","volume":"98","author":"Koeberle","year":"2015","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2021.105977_bib34","doi-asserted-by":"crossref","DOI":"10.1039\/C5RA25186A","article-title":"Chemistry and biology of microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors as novel anti-inflammatory agents: recent developments and current status","volume":"6","author":"Khurana","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.phrs.2021.105977_bib35","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1016\/j.joca.2018.02.698","article-title":"GRC 27864, novel, microsomal prostaglandin E synthase-1 enzyme inhibitor: phase 1 study to evaluate safety, PK and biomarkers in healthy, adult subjects","volume":"26","author":"Sant","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.phrs.2021.105977_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0021-9258(19)83739-0","article-title":"Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal","volume":"237","author":"Cohen","year":"1962","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2021.105977_bib37","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1073\/pnas.70.10.2964","article-title":"Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin","volume":"70","author":"Hollenberg","year":"1973","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.87.1.29","article-title":"Studies on plant hypertensinase","volume":"87","author":"Gollan","year":"1948","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.99.3.275","article-title":"The existence of two forms of hypertensin","volume":"99","author":"SKEGGS LT","year":"1954","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.phrs.2021.105977_bib40","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1021\/bi00852a046","article-title":"Studies on bovine factor X. I. Large-sclae purification of the bovine plasma protein possessing factor X activity","volume":"7","author":"Jackson","year":"1968","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.phrs.2021.105977_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/bj1310791","article-title":"The preparation of activated factor X and its action on prothrombin","volume":"131","author":"Jesty","year":"1973","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1113\/jphysiol.1958.sp006088","article-title":"The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat","volume":"144","author":"Bowman","year":"1958","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1476-5381.1970.tb10334.x","article-title":"Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle","volume":"38","author":"Bowman","year":"1970","journal-title":"Br. J. Pharmacol."},{"issue":"7338","key":"10.1016\/j.phrs.2021.105977_bib44","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(64)91577-6","article-title":"A chromosomal abnormality in a myelocytic aleukaemic leukaemia","volume":"1","author":"Makino","year":"1964","journal-title":"Lancet"},{"issue":"6105","key":"10.1016\/j.phrs.2021.105977_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/325635a0","article-title":"A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia","volume":"325","author":"Chan","year":"1987","journal-title":"Nature"},{"issue":"3632","key":"10.1016\/j.phrs.2021.105977_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.145.3632.593","article-title":"Specificity of potassium-activated phosphodiesterase of escherichia coli","volume":"145","author":"Singer","year":"1964","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.phrs.2021.105977_bib47","first-page":"1077","article-title":"Nucleases and adenosine 3\u2019,5\u2019-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice","volume":"61","author":"Tsou","year":"1978","journal-title":"J. Natl. Cancer Inst."},{"issue":"6259","key":"10.1016\/j.phrs.2021.105977_bib48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/343642a0","article-title":"Programmed death of autoreactive thymocytes","volume":"343","author":"MacDonald","year":"1990","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.phrs.2021.105977_bib49","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib50","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1073\/pnas.71.9.3400","article-title":"Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets","volume":"71","author":"Hamberg","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.phrs.2021.105977_bib51","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.89.11.4888","article-title":"cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase","volume":"89","author":"O\u2019Banion","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.phrs.2021.105977_bib52","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.96.13.7220","article-title":"Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target","volume":"96","author":"Jakobsson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.phrs.2021.105977_bib53","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1332766100","article-title":"Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase","volume":"100","author":"Trebino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2021.105977_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcp.2017.07.010","article-title":"Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis","volume":"142","author":"Zhou","year":"2017","journal-title":"Biochem Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.plefa.2013.08.003","article-title":"Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice","volume":"89","author":"Frolov","year":"2013","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.110621","article-title":"Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1","volume":"39","author":"Kapoor","year":"2012","journal-title":"J. Rheum."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib57","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/art.20286","article-title":"Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium","volume":"50","author":"Westman","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"Suppl 3","key":"10.1016\/j.phrs.2021.105977_bib58","first-page":"83","article-title":"Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes","volume":"6","author":"Xinfang","year":"2005","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2021.105977_bib59","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3389\/fphys.2018.01358","article-title":"Invalidation of microsomal prostaglandin E synthase-1 (mPGES-1) reduces diet-induced low-grade inflammation and adiposity","volume":"9","author":"Pierre","year":"2018","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib60","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/s41366-018-0235-6","article-title":"Inflammation increases MMP levels via PGE(2) in human vascular wall and plasma of obese women","volume":"43","author":"Ozen","year":"2019","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12944-018-0792-7","article-title":"Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia","volume":"17","author":"Mukai","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2021.105977_bib62","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nn1137","article-title":"Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis","volume":"6","author":"Engblom","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jalz.2007.10.015","article-title":"Elevated microsomal prostaglandin-E synthase\u20131 in Alzheimer\u2019s disease","volume":"4","author":"Chaudhry","year":"2008","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib64","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jnr.23217","article-title":"Microsomal prostaglandin E synthase-1 is induced in Alzheimer\u2019s disease and its deletion mitigates Alzheimer\u2019s disease-like pathology in a mouse model","volume":"91","author":"Akitake","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2021.105977_bib65","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.18632\/aging.101615","article-title":"Transferrin is responsible for mediating the effects of iron ions on the regulation of anterior pharynx-defective-1\u03b1\/\u03b2 and Presenilin 1 expression via PGE2 and PGD2 at the early stage of Alzheimer's Disease","volume":"10","author":"Lu","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.phrs.2021.105977_bib66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2018.11.004","article-title":"Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"124","author":"Ikeda-Matsuo","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib67","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/onc.2011.287","article-title":"Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1\/beta-catenin signaling axis","volume":"31","author":"Lu","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BJ20090045","article-title":"Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis","volume":"425","author":"Kamei","year":"2009","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib69","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjc.6601584","article-title":"Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas","volume":"90","author":"Takeda","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-009-0777-z","article-title":"Microsomal prostaglandin E synthase protein levels correlate with prognosis in colorectal cancer patients","volume":"454","author":"Seo","year":"2009","journal-title":"Virchows Arch."},{"issue":"21","key":"10.1016\/j.phrs.2021.105977_bib71","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1074\/jbc.M213290200","article-title":"Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis","volume":"278","author":"Kamei","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.phrs.2021.105977_bib72","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/onc.2011.472","article-title":"Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis","volume":"31","author":"Sasaki","year":"2012","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib73","first-page":"1669","article-title":"Hyperplastic gastric tumors induced by activated macrophages in COX-2\/mPGES-1 transgenic mice","volume":"23","author":"Hiroko","year":"2014","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib74","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-07-6100","article-title":"Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis","volume":"68","author":"Nakanishi","year":"2008","journal-title":"Cancer Res"},{"issue":"15\u201316","key":"10.1016\/j.phrs.2021.105977_bib75","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.lfs.2011.02.008","article-title":"Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice","volume":"88","author":"Isono","year":"2011","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib76","first-page":"F121","article-title":"Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction","volume":"312","author":"Luo","year":"2017","journal-title":"Am. J. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105977_bib77","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.18632\/oncotarget.24187","article-title":"Mitochondrial oxidative stress activates COX-2\/mPGES-1\/PGE2 cascade induced by albumin in renal proximal tubular cells","volume":"9","author":"Zhuang","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib78","doi-asserted-by":"crossref","first-page":"F492","DOI":"10.1152\/ajprenal.00499.2015","article-title":"mPGES-1-derived PGE2 contributes to adriamycin-induced podocyte injury","volume":"310","author":"Yu","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib79","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s41467-019-09492-4","article-title":"The cyclooxygenase-1\/mPGES-1\/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury","volume":"10","author":"Zhu","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib80","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/01.wnr.0000129372.89000.31","article-title":"Membrane-associated prostaglandin E synthase-1 is required for neuropathic pain","volume":"15","author":"Mabuchi","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2021.105977_bib81","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jpedsurg.2019.01.001","article-title":"MPGES-1 derived PGE2 inhibits cell migration by regulating ARP2\/3 in the pathogenesis of Hirschsprung disease","volume":"54","author":"Wu","year":"2019","journal-title":"J. Pedia Surg."},{"issue":"13","key":"10.1016\/j.phrs.2021.105977_bib82","doi-asserted-by":"crossref","first-page":"12647","DOI":"10.1074\/jbc.M312972200","article-title":"Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1","volume":"279","author":"Subbaramaiah","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/ar3285","article-title":"mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis","volume":"13","author":"Mccann","year":"2011","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"10.1016\/j.phrs.2021.105977_bib84","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ajpath.2010.12.048","article-title":"Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation","volume":"178","author":"B\u00e5ge","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105977_bib85","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.bcp.2010.01.003","article-title":"Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor","volume":"79","author":"Mbalaviele","year":"2010","journal-title":"Biochem. Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib86","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.bmcl.2010.01.060","article-title":"Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib87","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/rheumatology\/keh627","article-title":"Pharmacokinetic\u2013pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors","volume":"44","author":"Huntjens","year":"2005","journal-title":"Rheumatology"},{"issue":"20","key":"10.1016\/j.phrs.2021.105977_bib88","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1016\/j.bmcl.2014.08.056","article-title":"Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E2 synthase-1 inhibitors","volume":"24","author":"Banerjee","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2021.105977_bib89","unstructured":"Tandon, M., et al., mPGES-1 inhibitor for the treatment of osteoarthritis pain, P.a.T. Office, Editor. 2020, Google Patents: US."},{"issue":"12","key":"10.1016\/j.phrs.2021.105977_bib90","doi-asserted-by":"crossref","first-page":"13966","DOI":"10.1096\/fj.201901460RR","article-title":"Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier","volume":"33","author":"Soldner","year":"2019","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib91","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12967-021-03016-9","article-title":"Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice","volume":"19","author":"Gurusamy","year":"2021","journal-title":"J. Transl. Med."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2021.105977_bib92","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/annrheumdis-2020-eular.5503","article-title":"SAT0315\u2005inhibition of microsomal prostaglandin E synthase-1 (MPGES-1) by GS-248 reduces prostaglandin E2 biosynthesis while increasing prostacyclin in human subjects","volume":"79","author":"Edenius","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib93","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/jpet.115.228932","article-title":"Identification and characterization of novel microsomal prostaglandin E synthase-1 inhibitors for analgesia","volume":"356","author":"Chandrasekhar","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.jmedchem.5b01249","article-title":"Discovery and characterization of 2-acylaminoimidazole microsomal prostaglandin E synthase-1 inhibitors","volume":"59","author":"Schiffler","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib95","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.260","article-title":"Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib","volume":"99","author":"Jin","year":"2016","journal-title":"Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib96","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/acs.jmedchem.7b01806","article-title":"Identification and mitigation of reactive metabolites of 2-aminoimidazole-containing microsomal prostaglandin E synthase-1 inhibitors terminated due to clinical drug-induced liver injury","volume":"61","author":"Norman","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcp.13423","article-title":"Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor","volume":"84","author":"Jin","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib98","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.biotechadv.2018.02.010","article-title":"Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis","volume":"36","author":"Koeberle","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"11","key":"10.1016\/j.phrs.2021.105977_bib99","doi-asserted-by":"crossref","first-page":"G1071","DOI":"10.1152\/ajpgi.00327.2015","article-title":"Microsomal prostaglandin E synthase-1 protects against Fas-induced liver injury","volume":"310","author":"Yao","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2021.105977_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vetimm.2017.09.008","article-title":"Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE2 in an in vitro equine inflammation model","volume":"192","author":"Martin","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"24","key":"10.1016\/j.phrs.2021.105977_bib101","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.bmcl.2007.10.033","article-title":"Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors","volume":"17","author":"C\u00f4t\u00e9","year":"2007","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib102","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1038\/s41598-018-23482-4","article-title":"Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs","volume":"8","author":"Ding","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib103","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.108.139444","article-title":"Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1","volume":"326","author":"Koeberle","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"issue":"14","key":"10.1016\/j.phrs.2021.105977_bib104","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.bmcl.2005.05.027","article-title":"Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886","volume":"15","author":"Riendeau","year":"2005","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12185-011-0954-0","article-title":"MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis","volume":"94","author":"Li","year":"2011","journal-title":"Int. J. Hematol."},{"issue":"23","key":"10.1016\/j.phrs.2021.105977_bib106","doi-asserted-by":"crossref","first-page":"7924","DOI":"10.1016\/j.bmc.2009.10.025","article-title":"Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1","volume":"17","author":"Koeberle","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105977_bib107","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2018.05.041","article-title":"Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO\/m-PGES-1 dual inhibitors able to suppress inflammation","volume":"155","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105977_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.prostaglandins.2013.09.001","article-title":"Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation","volume":"107","author":"Leclerc","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.phrs.2021.105977_bib109","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1111\/bph.14827","article-title":"Biological characterization of new mPGES-1 inhibitors in preclinical models of inflammation and vascular tone","volume":"176","author":"Larsson","year":"2019","journal-title":"Br. J. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bmcl.2018.02.048","article-title":"Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series \u2013 Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: part-2","volume":"28","author":"Muthukaman","year":"2018","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.phrs.2021.105977_bib111","article-title":"IL-17-induced inflammation modulates the mPGES-1\/PPAR-\u03b3 pathway in monocytes\/macrophages","author":"Raucci","year":"2021","journal-title":"Br. J. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib112","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm0700823","volume":"50","author":"Guerrero","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105977_bib113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2009.08.007","article-title":"Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression","volume":"620","author":"Guerrero","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.phrs.2021.105977_bib114","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1016\/j.bmcl.2016.10.079","volume":"26","author":"Muthukaman","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bmcl.2016.11.011","article-title":"Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1","volume":"27","author":"Partridge","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2021.105977_bib116","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmcl.2019.07.007","article-title":"Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis","volume":"29","author":"Koppitz","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.phrs.2021.105977_bib117","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.bcp.2009.11.011","article-title":"Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro","volume":"79","author":"Bruno","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105977_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127992","article-title":"Discovery of N-amido-phenylsulfonamide derivatives as novel microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors","volume":"41","author":"Kim","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2021.105977_bib119","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.ejmech.2017.10.039","article-title":"Discovery of new potent molecular entities able to inhibit mPGES-1","volume":"143","author":"Di Micco","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.phrs.2021.105977_bib120","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1016\/j.bmc.2012.06.032","article-title":"Identification of new \u03b3-hydroxybutenolides that preferentially inhibit the activity of mPGES-1","volume":"20","author":"De Simone","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib121","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/jpet.109.160663","article-title":"The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"332","author":"Koeberle","year":"2010","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2021.105977_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106347","article-title":"A novel mPGES-1 inhibitor alleviates inflammatory responses by downregulating PGE2 in experimental models","volume":"144","author":"Lee","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"21","key":"10.1016\/j.phrs.2021.105977_bib123","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1016\/j.bmcl.2016.09.070","article-title":"Synthesis, structure determination, and biological evaluation of phenylsulfonyl hydrazide derivatives as potential anti-inflammatory agents","volume":"26","author":"Park","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib124","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.bmcl.2013.02.114","article-title":"Synthesis of indolyl-3-acetonitrile derivatives and their inhibitory effects on nitric oxide and PGE 2 productions in LPS-induced RAW 264.7 cells","volume":"23","author":"Kwon","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2021.105977_bib125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cbi.2014.10.004","article-title":"Anti-inflammatory effects of 7-hydroxyl-1-methylindole-3-acetonitrile, a synthetic arvelexin derivative, on the macrophages through destabilizing mPGES-1 mRNA and suppressing NF-\u03baB activation","volume":"224","author":"Shin","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib126","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1096\/fj.12-214445","article-title":"Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo","volume":"27","author":"Kats","year":"2013","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib127","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jcmm.14015","article-title":"Aminothiazoles inhibit osteoclastogenesis and PGE2 production in LPS-stimulated co-cultures of periodontal ligament and RAW 264.7 cells, and RANKL-mediated osteoclastogenesis and bone resorption in PBMCs","volume":"23","author":"Kats","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11030-011-9347-9","article-title":"Identification of furo[3\u2019, 2\u2019:3,4]naphtho[1,2-d]imidazole derivatives as orally active and selective inhibitors of microsomal prostaglandin E(2) synthase-1 (mPGES-1)","volume":"16","author":"Tseng","year":"2012","journal-title":"Mol. Divers."},{"issue":"12","key":"10.1016\/j.phrs.2021.105977_bib129","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.bmcl.2014.04.006","article-title":"Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1","volume":"24","author":"Shang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib130","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.108.138776","article-title":"MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation","volume":"326","author":"Xu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2021.105977_bib131","series-title":"Studies in Natural Products Chemistry","first-page":"115","article-title":"Chapter 4 - Phenolic derivatives from medicinal herbs and plant extracts: anticancer effects and synthetic approaches to modulate biological activity","author":"Roleira","year":"2018"},{"key":"10.1016\/j.phrs.2021.105977_bib132","series-title":"Studies in Natural Products Chemistry","first-page":"79","article-title":"Chapter 3 - Phenolic compounds: a good choice against chronic degenerative diseases","author":"Luna-Guevara","year":"2018"},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib133","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.105.084434","article-title":"Curcumin suppresses interleukin 1\u03b2-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways","volume":"315","author":"Moon","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2021.105977_bib134","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1535-7163.MCT-09-0290","article-title":"Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1","volume":"8","author":"Koeberle","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.phrs.2021.105977_bib135","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.jnatprod.5b00700","article-title":"Can small chemical modifications of natural pan-inhibitors modulate the biological selectivity? The case of curcumin prenylated derivatives acting as HDAC or mPGES-1 inhibitors","volume":"78","author":"Iranshahi","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib136","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/cbdd.12280","article-title":"Effects of novel diarylpentanoid analogues of curcumin on secretory phospholipase A2, cyclooxygenases, lipo-oxygenase, and microsomal prostaglandin E synthase-1","volume":"83","author":"Ahmad","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib137","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbrc.2009.08.005","article-title":"Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1","volume":"388","author":"Koeberle","year":"2009","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2021.105977_bib138","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.fob.2015.06.003","article-title":"Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice","volume":"5","author":"Tominari","year":"2015","journal-title":"FEBS Open Bio"},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/medicines5030089","article-title":"Antioxidant Activity of Myrtus communis L. and Myrtus nivellei Batt. & Trab. Extracts: A Brief Review","volume":"5","author":"Hennia","year":"2018","journal-title":"Medicines"},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib140","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1476-5381.2009.00070.x","article-title":"Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1","volume":"156","author":"Koeberle","year":"2009","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105977_bib141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fphar.2011.00007","article-title":"Hyperforin, an anti-inflammatory constituent from St. John\u2019s Wort, inhibits microsomal prostaglandin E(2) synthase-1 and suppresses prostaglandin E(2) formation in vivo","volume":"2","author":"Koeberle","year":"2011","journal-title":"Front. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib142","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1039\/C4FO00014E","article-title":"Extra virgin olive oil polyphenolic extracts downregulate inflammatory responses in LPS-activated murine peritoneal macrophages suppressing NF\u03baB and MAPK signalling pathways","volume":"5","author":"C\u00e1rdeno","year":"2014","journal-title":"Food Funct."},{"issue":"16","key":"10.1016\/j.phrs.2021.105977_bib143","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1158\/1078-0432.CCR-10-0156","article-title":"Inhibition of hypoxia inducible factor-1\u03b1 by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1\/vascular endothelial growth factor expression and reduces tumor angiogenesis","volume":"16","author":"Terzuoli","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib144","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1039\/C7FO00210F","article-title":"Oleuropein down-regulated IL-1\u03b2-induced inflammation and oxidative stress in human synovial fibroblast cell line SW982","volume":"8","author":"Castej\u00f3n","year":"2017","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib145","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/mnfr.201400163","article-title":"Punicalagin inhibits neuroinflammation in LPS-activated rat primary microglia","volume":"58","author":"Olajide","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phrs.2021.105977_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2017.05.003","article-title":"Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells","volume":"131","author":"Ranjbarnejad","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib147","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/np500198g","article-title":"Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1","volume":"77","author":"Verhoff","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2021.105977_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113639","article-title":"Nardosinanone N suppresses LPS-induced macrophage activation by modulating the Nrf2 pathway and mPGES-1","volume":"173","author":"Lio","year":"2020","journal-title":"Biochem. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105977_bib149","first-page":"519","article-title":"Anti-inflammatory effects of nortrachelogenin in murine J774 macrophages and in carrageenan-induced paw edema model in the mouse","volume":"83","author":"Laavola","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.phrs.2021.105977_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2018.05.010","article-title":"Inhibition of COX-2\/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation","volume":"351","author":"Liu","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105977_bib151","doi-asserted-by":"crossref","first-page":"167\/1","DOI":"10.1186\/s13046-016-0440-x","article-title":"The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells","volume":"35","author":"Zappavigna","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2021.105977_bib152","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmech.2015.02.042","article-title":"Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes","volume":"94","author":"Filosa","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105977_bib153","doi-asserted-by":"crossref","unstructured":"Hung, Y.-L., et al., Bavachin attenuates LPS-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages. Phytomedicine, 2019: p. Ahead of Print.","DOI":"10.1016\/j.phymed.2018.12.008"},{"key":"10.1016\/j.phrs.2021.105977_bib154","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jep.2018.04.042","article-title":"Lipophilic extracts of Leucas zeylanica, a multi-purpose medicinal plant in the tropics, inhibit key enzymes involved in inflammation and gout","volume":"224","author":"Napagoda","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/03009742.2014.927917","article-title":"Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes","volume":"44","author":"Tuure","year":"2015","journal-title":"Scand. J. Rheuma"},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib156","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3899\/jrheum.100907","article-title":"Valproic acid suppresses interleukin-1ss-induced microsomal prostaglandin E2 synthase-1 expression in chondrocytes through upregulation of NAB1","volume":"38","author":"Zayed","year":"2011","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2021.105977_bib157","doi-asserted-by":"crossref","first-page":"612971","DOI":"10.1155\/2013\/612971","article-title":"PPARgamma agonist rosiglitazone suppresses renal mPGES-1\/PGE2 pathway in db\/db mice","volume":"2013","author":"Sun","year":"2013","journal-title":"PPAR Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib158","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2008.04.008","article-title":"Dimethylcelecoxib inhibits prostaglandin E2 production","volume":"76","author":"Wobst","year":"2008","journal-title":"Biochem. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib159","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bcp.2010.07.032","article-title":"Dimethylcelecoxib inhibits mPGES-1 promoter activity by influencing EGR1 and NF-\u03baB","volume":"80","author":"Deckmann","year":"2010","journal-title":"Biochem. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cellsig.2011.09.025","article-title":"Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1\/NF-\u03baB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1","volume":"24","author":"Deckmann","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2021.105977_bib161","doi-asserted-by":"crossref","first-page":"372750","DOI":"10.1155\/2015\/372750","article-title":"Downregulation of mPGES-1 expression via EGR1 plays an important role in inhibition of caffeine on PGE2 synthesis of HBx(+) hepatocytes","volume":"2015","author":"Ma","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2021.105977_bib162","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biochi.2019.02.004","article-title":"Morphine, but not methadone, inhibits microsomal prostaglandin E synthase-1 and prostaglandin-endoperoxide synthase 2 in lipopolysaccharide-stimulated horse synoviocytes","volume":"160","author":"Schwarzbach","year":"2019","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.phrs.2021.105977_bib163","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.110621","article-title":"Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1","volume":"39","author":"Kapoor","year":"2012","journal-title":"J. Rheuma"},{"issue":"17","key":"10.1016\/j.phrs.2021.105977_bib164","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1016\/j.bmc.2014.07.007","article-title":"A semi-synthetic derivative of artemisinin, artesunate inhibits prostaglandin E2 production in LPS\/IFNgamma-activated BV2 microglia","volume":"22","author":"Okorji","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2021.105977_bib165","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1007\/s12035-015-9543-1","article-title":"Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms","volume":"53","author":"Okorji","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib166","first-page":"422","article-title":"Dihydroartemisinin inhibits indoxyl sulfate (IS)-promoted cell cycle progression in mesangial cells by targeting COX-2\/mPGES-1\/PGE2 cascade","volume":"10","author":"Mungun","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib167","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000480369","article-title":"mPGES-1-derived PGE2 contributes to indoxyl sulfate-induced mesangial cell proliferation","volume":"43","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib168","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jcb.25401","article-title":"Statins modulate cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in human hepatic myofibroblasts","volume":"117","author":"Mouawad","year":"2016","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.phrs.2021.105977_bib169","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fphar.2017.00646","article-title":"Microsomal prostaglandin E synthase-1 expression in inflammatory conditions is downregulated by dexamethasone: seminal role of the regulatory phosphatase MKP-1","volume":"8","author":"Tuure","year":"2017","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2021.105977_bib170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.intimp.2019.03.014","article-title":"Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1)","volume":"71","author":"Tuure","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-017-0849-3","article-title":"Commentary: why pharmaceutical scientists in early drug discovery are critical for influencing the design and selection of optimal drug candidates","volume":"19","author":"Landis","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib172","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharm. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2021.105977_bib173","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03639045.2011.602406","article-title":"Selection of oral bioavailability enhancing formulations during drug discovery","volume":"38","author":"Zheng","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"17","key":"10.1016\/j.phrs.2021.105977_bib174","first-page":"16579","article-title":"Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages","volume":"280","author":"Trebino","year":"2005","journal-title":"J. Biochem."},{"key":"10.1016\/j.phrs.2021.105977_bib175","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1042\/CS20160463","article-title":"mPGES-1 deletion affects platelet functions in mice","volume":"130","author":"Raouf","year":"2016","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105977_bib176","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","article-title":"Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function","volume":"116","author":"Cheng","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"22","key":"10.1016\/j.phrs.2021.105977_bib177","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1111\/bph.13939","article-title":"Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI2: a safer alternative to COX-2 inhibition","volume":"174","author":"Ozen","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.phrs.2021.105977_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133141","article-title":"Selenium and glutathione-depleted rats as a sensitive animal model to predict drug-induced liver injury in humans","volume":"20","author":"Goda","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105977_bib179","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14756366.2019.1587416","article-title":"CRISPR\/Cas9-based liver-derived reporter cells for screening of mPGES-1 inhibitors","volume":"34","author":"Chen","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821005612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821005612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:26:41Z","timestamp":1760912801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821005612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":179,"alternative-id":["S1043661821005612"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105977","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105977"}}